Citations 1
EMBER-4: a Phase 3 adjuvant trial of imlunestrant vs standard endocrine therapy in patients with ER+, HER2− early breast cancer with an increased risk of recurrence who have previously received 2 to 5 years of adjuvant ET
O’Shaughnessy, Joyce , Thomas, Z. M., Young, Stephanie, Ismail‐Khan, Roohi , Smyth, Lillian M. , Harbeck, Nadia , Jhaveri, Komal , André, Fabrice , Goetz, Matthew P. , Martín, Miguel , Bidard, Francois-Clément , Young, S. R., Gnant, Michael
Senologie - Zeitschrift für Mammadiagnostik und -therapie | July 12, 2023 | Volume: 20 | Issue: 02 | Pages: e6-e7
